Table 2 Descriptive statistics for offspring CBCL, MSEL, and ADOS scores in the maternal immune and maternal non-immune groups.

From: Maternal immune conditions are increased in males with autism spectrum disorders and are associated with behavioural and emotional but not cognitive co-morbidity

 

Full cohorta

Maternal immune group

Maternal non-immune group

CBCL Internalizing, mean (SD)

62.05 (9.33)

62.95 (8.50)

61.72 (9.62)

CBCL Externalizing, mean (SD)

59.01 (10.61)

60.36 (10.47)

58.49 (10.65)

CBCL Total, mean (SD)

62.23 (10.54)

64.01 (9.81)

61.89 (10.76)

CBCL Internalizing >60, n (%)

184 (50.69)

56 (65.88)

128 (56.39)

CBCL Externalizing >60, n (%)

139 (38.29)

47 (53.41)

92 (40.00)

CBCL Total >60, n (%)

164 (45.18)

53 (69.74)

111 (54.41)

MSEL VDQ, mean (SD)

56.56 (25.25)

61.13 (24.81)

54.80 (25.25)

MSEL NVDQ, mean (SD)

69.74 (19.00)

75.11 (18.62)

67.68 (18.78)

MSEL DQ, mean (SD)

63.17 (20.64)

68.19 (19.61)

61.24 (20.74)

ADOS CSS-SA, mean (SD)

6.99 (1.67)

6.91 (1.77)

7.02 (1.64)

ADOS CSS-RRB, mean (SD)

8.42 (1.53)

8.30 (1.46)

8.46 (1.56)

ADOS CSS, mean (SD)

7.56 (1.72)

7.47 (1.77)

7.60 (1.70)

  1. SD standard deviation, CBCL Child Behaviour Checklist, MSEL Mullens Scales of Early Learning, VDQ verbal developmental quotient, NVDQ nonverbal developmental quotient, DQ developmental quotient, ADOS Autism Diagnostic Observation Schedule, CSS calibrated severity score, SA social affect, RRB restricted repetitive behaviour.
  2. aPercentage of missing data in each measure for the full cohort: CBCL Internalizing 14%, CBCL Externalizing 12%, CBCL Total 23%, MSEL VDQ 3%, MSEL NVDQ 3%, MSEL DQ 2%, ADOS all scales 3%.
Back to article page